As reported by Memorial Sloan Kettering, researchers there have learned how chromosomal instability allows cancer cells to avoid immune defenses […]
The social determinants of health (SDoE) are real: one’s social, economic and ethnic or racial background may actually contribute to […]
Dr. Steven Sugarman with Memorial Sloan Kettering Cancer Center’s facility in Commack is making a difference in cancer patient’s lives. Sugarman […]
The FASEB Journal, put out by The Federation of American Societies for Experimental Biology, published a manuscript on August 11 […]
Since there exists uncertainty regarding the effectiveness of local surgery for bone metastases (BM) originating from renal cell carcinoma (RCC), […]
Memorial Sloan Kettering Cancer Center is conducting a Phase 2 pleural mesothelioma clinical trial using lung-sparing surgery along with chemotherapy […]
Patients with RET-fusion-positive non-small cell lung cancer (NSCLC) had a high response to LOXO-292 (selpercatinib), according to findings from the […]
Memorial Sloan Kettering Cancer Center (MSK) announced that the New York State Department of Health has issued an approval for […]
TrialSite News re-posts recent news from Memorial Sloan Kettering Cancer Center. Recent regulatory changes in China have shaved years off […]
As reported in the New York Times by Katie Thomas and Charles Ornstein, Dr. Gregory Raskin who led Memorial Sloan […]
